Back to search

Article

Clinicopathological signature and prognostic value of RNA:m5C methyltransferases in gliomas

2020-02-04

Abstract excerpt

<title>Abstract</title> <p>Background: Glioma is the most common primary intracranial tumor, accounting for the vast majority of intracranial malignant tumors. Aberrant expression of RNA:5-methylcytosine(m5C) methyltransferases has recently been the focus of research relating to the occurrence and progression of tumors. However, the prognostic value of RNA:m5C methyltransferases in glioma remains unclear. This st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a0c224f4-e891-5b0e-8e84-68d5a05d9e11
DOI
10.21203/rs.2.22601/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinicopathological signature and prognostic value of RNA:m5C methyltransferases in gliomasDOI 10.21203/rs.2.22601/v1
Integrated analysis from multicentre studies identities RNA methylation- related lncRNA risk stratification systems for gliomaSemantic proximity
An m1A/m6A/m7G/m5C regulator-mediated methylation modification pattern and Landscape of immune microenvironment infiltration characterization in Lower-Grade Glioma cohorts from three continents based on machine learningSemantic proximity
Molecular and clinical characterization of 5mC regulators in glioma: results of a multicenter studySemantic proximity
Identification of N6-Methyladenosine-Related Gene Based Prognostic Signature to Predict Survival and Potential Therapeutic Drugs in GliomaSemantic proximity
m1A RNA Methylation Regulators Contribute To Malignant Progression And Have Clinical Prognostic Impact In GliomasSemantic proximity
Identification of a three-long non-coding RNA signature for predicting survival of temozolomide-treated isocitrate dehydrogenase mutant low-grade gliomas.Semantic proximity
Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in gliomaSemantic proximity
Long Noncoding RNA Profiles Reveal Three Molecular Subtypes in GliomaSemantic proximity
Identification and Validation of RNA Methylation-Related Related Alternative Splicing Gene Signature for Low Grade Glioma to Predict Survival and Immune LandscapesSemantic proximity
The Prognostic Value and Immune Landscaps of m6A/m5C-related LncRNAs signature in the Low Grade GliomaSemantic proximity
N6-Methyladenosine methylome landscape and a novel m6A-related gene risk signature associated with the prognosis of glioblastomaSemantic proximity
Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis.Semantic proximity
Select a neighboring publication to make it the new centre.